| Entry |
|
|---|
| Name |
Solriamfetol (USAN) |
|---|
| Formula |
C10H14N2O2
|
|---|
| Exact mass |
194.1055
|
|---|
| Mol weight |
194.23
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG03059 Noradrenalin and dopamine reuptake inhibitor (NDRI)
|
|---|
| Remark |
| Product (DG02989): | D11328<US> |
|
|---|
| Efficacy |
Wake-promoting agent, Noradrenalin and dopamine reuptake inhibitor |
|---|
| Comment |
Wake-promoting agent for the treatment of excessive sleepiness associated with narcolepsy or obstructive sleep apnea
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
N06BA Centrally acting sympathomimetics
N06BA14 Solriamfetol
D11315 Solriamfetol (USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03059 Noradrenalin and dopamine reuptake inhibitor (NDRI)
DG02989 Sorliamfetol
D11315 Solriamfetol
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D11315 Solriamfetol (USAN)
SLC6A3 (DAT1)
D11315 Solriamfetol (USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03059 Noradrenalin and dopamine reuptake inhibitor (NDRI)
DG02989 Sorliamfetol
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 14
1 C8x C 4.9000 -17.5700
2 C8x C 4.9000 -18.9700
3 C8x C 6.1124 -19.6700
4 C8x C 7.3249 -18.9700
5 C8y C 7.3249 -17.5700
6 C8x C 6.1124 -16.8700
7 C1b C 8.5560 -16.8590
8 C1c C 9.7612 -17.5547
9 C1b C 10.9435 -16.8719
10 O7a O 12.1375 -17.5612
11 C7a C 13.3254 -16.8752
12 N1a N 14.5165 -17.5629
13 O6a O 13.3255 -15.4702
14 N1a N 9.7616 -18.9696
BOND 14
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 11 13 2
14 8 14 1 #Down
|
|---|
